{
  "_id": "6802917a3ccffd1c7912c99f",
  "ipo_id": "2020_gland_pharma_limited_ipo",
  "__v": 0,
  "_metadata": {
    "sectionsAvailable": {
      "basicDetails": true,
      "tentativeSchedule": true,
      "lotSize": true,
      "timeline": false,
      "kpi": false,
      "financials": true,
      "promoterHolding": true,
      "objectives": false,
      "about": true,
      "subscriptionStatus": true,
      "contactDetails": true,
      "registrarDetails": true,
      "leadManagers": true,
      "listingDetails": true,
      "listingDayTrading": true,
      "faqs": true,
      "recommendationSummary": true,
      "prospectusLinks": true,
      "reservation": true,
      "anchorInvestors": false
    },
    "scrapedAt": "2025-04-18T17:42:21.202Z",
    "sourceUrl": "https://www.chittorgarh.com/ipo/gland-pharma-ipo/1072/"
  },
  "about": {
    "details": "<p>Gland Pharma Ltd, the Hyderabad-based company is one of the fastest-growing generic injectable companies. It manufactures a diversified range of high-quality complex injectables. The company offers products like sterile injectables, oncology, and ophthalmics, complex injectables (peptides, suspensions, hormonal products, long-acting injectables), NCE-1s, First-to-File products, etc.</p>\n<p>The company follows a B2B model to sell its products in more than 60 countries including the US, Canada, Australia, India, Europe, etc. Leading pharma companies i.e. Sagent Pharmaceuticals, Apotex Inc. Athnex Pharmaceutical Division, LLC, Fresenius Kabi USA, LLC, etc. are some of the key customers.</p>\n<p>It has 7 robust manufacturing units in India comprising 4 finished formulations facilities, 22 production lines, and 3 APIs.</p>\n<p><strong>Company Strengths</strong></p>\n<ul>\n<li>The extensive product portfolio of complex injectables.</li>\n<li>Diversified B2B model with a targeted B2C model in India.</li>\n<li>Strong manufacturing capabilities.</li>\n<li>Robust financial track record.</li>\n<li>Experienced and qualified managerial team.</li>\n</ul>"
  },
  "additionalTables": [
    {
      "heading": "Company Financials",
      "sanitizedHeading": "financials",
      "headers": [
        "Particulars",
        "For the year/period ended (Rs in million)"
      ],
      "rows": [
        [
          null,
          "30-June-20",
          "31-Mar-20",
          "31-Mar-19",
          "31-Mar-18"
        ],
        [
          "Total Assets",
          "46912.65",
          "40860.39",
          "35235.49",
          "29294.68"
        ],
        [
          "Total Revenue",
          "9162.89",
          "27724.08",
          "21297.67",
          "16716.82"
        ],
        [
          "Profit After Tax",
          "3135.90",
          "7728.58",
          "4518.56",
          "3210.51"
        ]
      ]
    }
  ],
  "basicDetails": {
    "ipoDate": "November 9, 2020 to November 11, 2020",
    "ipoListingDate": "Fri, Nov 20, 2020",
    "faceValue": "₹1 per share",
    "issuePrice": "₹1,500.00",
    "lotSize": "10 Shares",
    "issueSize": "4,31,96,968 shares (aggregating up to ₹6,479.55 Cr)",
    "freshIssue": "83,33,333 shares (aggregating up to ₹1,250.00 Cr)",
    "offerForSale": "3,48,63,635 shares of ₹1 (aggregating up to ₹5,229.55 Cr)",
    "issueType": "Bookbuilding IPO",
    "listingAt": "BSE, NSE",
    "ipoOpenDate": "Mon, Nov 9, 2020",
    "ipoCloseDate": "Wed, Nov 11, 2020",
    "initiationOfRefunds": "Wed, Nov 18, 2020",
    "creditOfSharesToDemat": "Thu, Nov 19, 2020",
    "shareHoldingPreIssue": "15,49,49,490 shares",
    "shareHoldingPreIssueAll": [
      {
        "label": "Share Holding Pre Issue",
        "value": "15,49,49,490 shares"
      },
      {
        "label": "Share Holding Pre Issue",
        "value": "74%"
      }
    ],
    "shareHoldingPostIssue": "16,32,82,823 shares",
    "shareHoldingPostIssueAll": [
      {
        "label": "Share Holding Post Issue",
        "value": "16,32,82,823 shares"
      },
      {
        "label": "Share Holding Post Issue",
        "value": "58%"
      }
    ]
  },
  "closing_date": "2020-11-10T18:30:00.000Z",
  "contactDetails": {
    "phone": "+91 40 3051 0999",
    "email": "investors@glandpharma.com",
    "full_address": "Gland Pharma Limited, Sy. No. 143 - 148 150 and 151, Near Gandi Maisamma 'X' Roads D.P. PallyDundigal, Medchal-Malkajgiri District Hyderabad",
    "website": "http://www.glandpharma.com"
  },
  "createdAt": "2025-04-18T17:52:57.870Z",
  "faqs": [
    {
      "question": "What is the Gland Pharma IPO?",
      "answer": "<div itemprop=\"text\"><p>Gland Pharma IPO<!-- --> is a <b>main-board<!-- --> <!-- -->IPO<!-- --> of <!-- -->43196968<!-- --> equity shares</b> of the face value of ₹<!-- -->1<!-- --> aggregating up to ₹<!-- -->6,479.55<!-- --> Crores. The issue is priced at <span>₹1500 per share</span>. The minimum order quantity is <!-- -->10<!-- -->.</p><p>The <!-- -->IPO<!-- --> <b>opens on <!-- -->November 9, 2020</b>, and <b>closes on <!-- -->November 11, 2020</b>.</p><p>Link Intime India Private Ltd<!-- --> is the registrar for the <!-- -->IPO<!-- -->. The shares are proposed to be listed on <!-- -->BSE, NSE<!-- -->.</p></div>"
    },
    {
      "question": "How to apply in Gland Pharma IPO through Zerodha?",
      "answer": "<div itemprop=\"text\"><p>Zerodha customers can apply online in <!-- -->Gland Pharma IPO<!-- --> using UPI as a payment gateway. Zerodha customers can apply in <!-- -->Gland Pharma IPO<!-- --> by login into Zerodha Console (back office) and submitting an IPO application form.</p><p><strong>Steps to apply in <!-- -->Gland Pharma IPO<!-- --> through Zerodha</strong></p><ol><li>Visit the Zerodha website and login to Console.</li><li>Go to Portfolio and click the IPOs link.</li><li>Go to the '<!-- -->Gland Pharma IPO<!-- -->' row and click the 'Bid' button.</li><li>Enter your UPI ID, Quantity, and Price.</li><li>Submit IPO application form.</li><li>Visit the UPI App (net banking or BHIM) to approve the mandate.</li></ol><p>Visit <a href=\"/broker/zerodha/ipo/18/\" title=\"Zerodha IPO Application Process Review\">Zerodha IPO Application Process Review</a> for more detail.</p></div>"
    },
    {
      "question": "When Gland Pharma IPO will open?",
      "answer": "<div itemprop=\"text\"><p>The Gland Pharma IPO opens on November 9, 2020 and closes on November 11, 2020.</p></div>"
    },
    {
      "question": "What is the lot size of Gland Pharma IPO?",
      "answer": "<div itemprop=\"text\"><p>Gland Pharma IPO<!-- --> <b>lot size is <!-- -->10</b>, and the <b>minimum amount required is <span>₹15,000</span></b>.</p></div>"
    },
    {
      "question": "How to apply for Gland Pharma IPO?",
      "answer": "<div itemprop=\"text\"><p>You can apply in <!-- -->Gland Pharma IPO<!-- --> online using either <a href=\"/article/upi-payment-option-ipo-application-explained/382/\">UPI</a> or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through <a href=\"/broker/zerodha/ipo/18/\" title=\"Zerodha IPO Review\"><b>Zerodha</b></a>, <a href=\"/broker/upstox/ipo/33/\" title=\"Upstox IPO Review\">Upstox</a>, <a href=\"/broker/5paisa/ipo/4/\" title=\"5Paisa IPO Review\">5Paisa</a>, <a href=\"/broker/edelweiss_broking/ipo/34/\" title=\"Nuvama IPO Review\">Nuvama</a>, <a href=\"/broker/hdfc-securities/ipo/6/\" title=\"HDFC Bank IPO Review\">HDFC Bank</a>, and <a href=\"/broker/sbi-capital/ipo/19/\" title=\"SBI Capital IPO Review\">SBI Bank</a>.</p></div>"
    },
    {
      "question": "When is Gland Pharma IPO allotment?",
      "answer": "<div itemprop=\"text\"><p>The finalization of Basis of Allotment for <!-- -->Gland Pharma IPO<!-- --> will be done on <!-- -->Tuesday, November 17, 2020<!-- -->, and the allotted shares will be credited to your demat account by <!-- -->Thursday, November 19, 2020<!-- -->. Check the <a href=\"/ipo_allotment_status/gland-pharma-ipo/1072/\" title=\"Gland Pharma IPO Allotment Status\">Gland Pharma IPO<!-- --> allotment status</a>.</p></div>"
    },
    {
      "question": "When is Gland Pharma IPO listing date?",
      "answer": "<div itemprop=\"text\"><p>The <!-- -->Gland Pharma IPO<!-- --> listing date is on <b>Friday, November 20, 2020</b>.</p></div>"
    }
  ],
  "ipoName": "Gland Pharma",
  "issue_price": "₹1,500.00",
  "issue_price_numeric": 1,
  "issue_size": "4,31,96,968 shares (aggregating up to ₹6,479.55 Cr)",
  "issue_size_numeric": 4,
  "leadManagerReports": [
    {
      "text": "IPO Lead Manager Performance Summary",
      "url": "/report/ipo_lead_manager_performance_tracker/19/"
    },
    {
      "text": "IPO Lead Manager Performance Tracker",
      "url": "/report/ipo-lead-manager-vs-listing-gain/99/17/"
    }
  ],
  "leadManagers": [
    {
      "name": "Citigroup Global Markets India Private Limited",
      "url": "/report/ipo-lead-manager-review/112/23/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/23/"
    },
    {
      "name": "Haitong Securities India Private Limited",
      "url": "/report/ipo-lead-manager-review/112/135/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/135/"
    },
    {
      "name": "Kotak Mahindra Capital Company Limited",
      "url": "/report/ipo-lead-manager-review/112/12/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/12/"
    },
    {
      "name": "Nomura Financial Advisory And Securities",
      "url": "/report/ipo-lead-manager-review/112/72/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/72/"
    }
  ],
  "listingDayTrading": {
    "data": {
      "final_issue_price": {
        "bse": "1500.00",
        "nse": "1500.00"
      },
      "open": {
        "bse": "1701.00",
        "nse": "1710.00"
      },
      "low": {
        "bse": "1701.00",
        "nse": "1700.00"
      },
      "high": {
        "bse": "1850.00",
        "nse": "1850.00"
      },
      "last_trade": {
        "bse": "1820.45",
        "nse": "1819.55"
      }
    },
    "performance_link": {
      "text": "Check IPO Performance…",
      "url": "/ipo/ipo_perf_tracker.asp"
    }
  },
  "listingDetails": {
    "pre_open_links": [
      {
        "text": "Pre-Open Session - NSE",
        "url": "https://www.nseindia.com/market-data/new-stock-exchange-listings-today"
      },
      {
        "text": "Pre-Open Session - BSE",
        "url": "https://www.bseindia.com/eqstreamer/StockTickerSplPreOpen.html"
      }
    ],
    "ipo_date": "November 20 2020",
    "bse_script_code": "543245",
    "nse_symbol": "GLAND",
    "isin": "INE068V01023",
    "final_issue_price": "1500 per share"
  },
  "listing_date": "2020-11-19T18:30:00.000Z",
  "listing_gains": "21.36%",
  "listing_gains_numeric": 21.36,
  "logo": "https://www.chittorgarh.net/images/ipo/gland_pharma_ipo_logo.png",
  "logo_url": "https://www.chittorgarh.net/images/ipo/gland_pharma_ipo_logo.png",
  "lotSize": {
    "summary": "Investors can bid for a minimum of 10 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.",
    "applications": {
      "retail_min": {
        "application": "Retail (Min)",
        "lots": "1",
        "shares": "10",
        "amount": "15000"
      },
      "retail_max": {
        "application": "Retail (Max)",
        "lots": "13",
        "shares": "130",
        "amount": "195000"
      },
      "shni_min": {
        "application": "S-HNI (Min)",
        "lots": "14",
        "shares": "140",
        "amount": "210000"
      },
      "shni_max": {
        "application": "S-HNI (Max)",
        "lots": "66",
        "shares": "660",
        "amount": "990000"
      },
      "bhni_min": {
        "application": "B-HNI (Min)",
        "lots": "67",
        "shares": "670",
        "amount": "1005000"
      },
      "lot_size": {
        "application": "Lot Size Calculator"
      }
    },
    "calculator_link": {
      "text": "Lot Size Calculator",
      "url": "/ipo-hni-funding-cost-calculator/gland-pharma-ipo/1072/"
    }
  },
  "lot_size": 10,
  "opening_date": "2020-11-08T18:30:00.000Z",
  "pageHeading": "Gland Pharma Limited IPO (Gland Pharma IPO) Detail",
  "pageTitle": "Gland Pharma IPO Date, Price, GMP, Review, Details",
  "promoterHolding": {
    "promoters": "Fosun Pharma Industrial Pte. Ltd and Shanghai Fosun Pharmaceutical (Group) Co. Ltd is the company promoters.",
    "holdings": {
      "share_holding_pre_issue": "74%",
      "share_holding_post_issue": "58%"
    },
    "note": "The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue"
  },
  "prospectusLinks": [
    {
      "text": "Gland Pharma IPO DRHP",
      "url": "https://www.sebi.gov.in/filings/public-issues/jul-2020/gland-pharma-limited_47048.html"
    },
    {
      "text": "Gland Pharma IPO RHP",
      "url": "https://www.sebi.gov.in/filings/public-issues/nov-2020/gland-pharma-limited-prospectus_48166.html"
    }
  ],
  "recommendationSummary": {
    "recommendations": {
      "brokersbrokers": {
        "subscribe": "8",
        "neutral": "0",
        "avoid": "0"
      },
      "membersmembers": {
        "subscribe": "0",
        "neutral": "0",
        "avoid": "0"
      }
    },
    "links": [
      {
        "text": "Read All Reviews",
        "url": "/ipo-recommendation/gland-pharma-ipo/1072/"
      },
      {
        "text": "Post Your Review",
        "url": "#"
      },
      {
        "text": "Manage Reviews",
        "url": "#"
      }
    ]
  },
  "registrarDetails": {
    "name": "Link Intime India Private Ltd",
    "phone": "+91-22-4918 6270",
    "email": "glandpharma.ipo@linkintime.co.in",
    "website": "https://linkintime.co.in/Initial_Offer/public-issues.html"
  },
  "reservation": {
    "summary": "Gland Pharma IPO offers 30237879 shares. 8639394 (28.57%) to QIB 6479546 (21.43%) to NII 15118939 (50.00%) to RII. 1511893 RIIs will receive minimum 10 shares and (sNII) and (bNII) will receive minimum 140 shares. (in case of oversubscription)",
    "allocation": [
      {
        "investor_category": "Anchor Investor Shares Offered",
        "shares_offered": "-",
        "maximum_allottees": "NA"
      },
      {
        "investor_category": "QIB Shares Offered",
        "shares_offered": "8639394 (28.57%)",
        "maximum_allottees": "NA"
      },
      {
        "investor_category": "NII (HNI) Shares Offered",
        "shares_offered": "6479546 (21.43%)"
      },
      {
        "investor_category": "Retail Shares Offered",
        "shares_offered": "15118939 (50.00%)",
        "maximum_allottees": "1511893"
      },
      {
        "investor_category": "Total Shares Offered",
        "shares_offered": "30237879 (100%)"
      }
    ]
  },
  "scraped_at": "2025-04-18T17:52:57.869Z",
  "source_url": "",
  "status": "listed",
  "subscriptionStatus": {
    "summary": "The Gland Pharma IPO is subscribed 2.06 times on November 11 2020 6:00:01 PM (Day 3). The public issue subscribed 0.24 times in the retail category 6.4 times in the QIB category and 0.51 times in the NII category. Check Day by Day Subscription Details (Live Status)",
    "overall": {
      "qib": {
        "category": "QIB",
        "subscription_times": "6.4",
        "shares_offered": "8639394",
        "shares_bid_for": "55250350"
      },
      "nii": {
        "category": "NII",
        "subscription_times": "0.51",
        "shares_offered": "6479546",
        "shares_bid_for": "3294470"
      },
      "retail": {
        "category": "Retail",
        "subscription_times": "0.24",
        "shares_offered": "15118939",
        "shares_bid_for": "3610850"
      },
      "total": {
        "category": "Total",
        "subscription_times": "2.06",
        "shares_offered": "30237879",
        "shares_bid_for": "62155670"
      }
    }
  },
  "tentativeDetails": {
    "ipo_date": "5 PM on November 11 2020",
    "tentative_allotment": "Tue Nov 17 2020",
    "initiation_of_refunds": "Wed Nov 18 2020",
    "credit_of_shares_to_demat": "Thu Nov 19 2020"
  },
  "updatedAt": "2025-04-19T04:37:58.299Z",
  "updated_at": "2025-04-18T17:52:57.869Z",
  "year": 2020,
  "worst_listing_gains": "21.36%",
  "worst_listing_gains_numeric": 21.36
}